In 2024, Eesti Transfusioonmeditsiini Selts had revenue of 4.6 thousand EUR. Beneficial owners: Ave Lellep, Eve Laansoo, Merle Keps and 2 more.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 4,6k € -1.6% | 4,7k € +7.8% | 4,4k € -4.1% |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | B67/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 50/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - | |||
| - | Board member | - | |||
| - | Board member | - | |||
| - | Board member | - | |||
| - | Board member | - |
Eesti Transfusioonmeditsiini Selts is located at Harju maakond, Tallinn, Põhja-Tallinna linnaosa, Ädala tn 2, 10614.
The beneficial owners of Eesti Transfusioonmeditsiini Selts are Ave Lellep, Eve Laansoo, Merle Keps, Rahel Reimal and Riin Kullaste. View ownership details →
No, Eesti Transfusioonmeditsiini Selts does not have an active VAT number and is not registered as a VAT payer.
Eesti Transfusioonmeditsiini Selts was founded on April 14, 2004. The company has been operating for 22 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 22 years | 54 - 58 | 94% | |
Net revenue | 4625,00 € | 651 - 655 | 31% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Estonian business register.
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Ave Lellep | EE | - | |
| Eve Laansoo | EE | - | |
| Merle Keps | EE | - | |
| Rahel Reimal | EE | - | |
| Riin Kullaste | EE | - |